The global stem cell UCB market to grow at a CAGR of 30.36% over the period 2014-2019

UCB is the blood that remains in the placenta and the attached umbilical cord after childbirth. UCB contains stem cells that are unique, smart, and are capable of treating several life-threatening diseases. They are used in the treatment of hematopoietic …

[Read the full article here]

Comments are closed.